Japan Medical Dynamic Marketing Valuation

Q: What is the Fair Price of 7600 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

7600 (¥617) is trading above our estimate of [[fair value]] (¥488.72)

Is 7600 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 7600 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 7600 (¥617) is trading above our estimate of fair value (¥488.72)

Significantly Below Fair Value: 7600 is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 7600?

Key metric: As 7600 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 7600. This is calculated by dividing 7600's market cap by their current earnings.
What is 7600's PE Ratio?
PE Ratio	11.5x
Earnings	JP¥1.41b
Market Cap	JP¥16.25b

7600 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	0.7x
Enterprise Value/EBITDA	4.8x
PEG Ratio	0.8x

Price to Earnings Ratio vs Peers

How does 7600's PE Ratio compare to its peers?

The above table shows the PE ratio for 7600 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	10.3x
3055 Hokuyaku Takeyama HoldingsInc	7.6x	n/a	JP¥17.8b
3154 Medius Holdings	15.5x	n/a	JP¥17.3b
7488 Yagami	11.8x	n/a	JP¥14.9b
3417 Ohki Healthcare HoldingsLtd	6.2x	n/a	JP¥11.5b
7600 Japan Medical Dynamic Marketing	11.5x	14.9%	JP¥16.2b

Price-To-Earnings vs Peers: 7600 is expensive based on its Price-To-Earnings Ratio (11.5x) compared to the peer average (10.3x).

Price to Earnings Ratio vs Industry

How does 7600's PE Ratio compare vs other companies in the JP Healthcare Industry?

0 Companies	Price / Earnings	Estimated Growth	Market Cap

No more companies available in this PE range

0 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Earnings vs Industry: 7600 is good value based on its Price-To-Earnings Ratio (11.5x) compared to the JP Healthcare industry average (14x).

Price to Earnings Ratio vs Fair Ratio

What is 7600's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

7600 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	11.5x
Fair PE Ratio	16.5x

Price-To-Earnings vs Fair Ratio: 7600 is good value based on its Price-To-Earnings Ratio (11.5x) compared to the estimated Fair Price-To-Earnings Ratio (16.5x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

FINDEX

JP¥20.5b

Offers medical systems, office systems, and Healthtech products in Japan.

3649

JP¥800.00

-0.7%

-12.5%

Charm Care

JP¥40.4b

Engages in nursing care business.

6062

JP¥1,238.00

2.1%

4.5%

Suzuken

JP¥383.2b

Primarily engages in the distribution of pharmaceuticals in Japan and internationally.

9987

JP¥4,936.00

-2.8%

-1.8%